dc.creatorBrito, Alex
dc.creatorVerdugo Latorre, Renato
dc.creatorHertrampf, Eva
dc.creatorMiller, Joshua W.
dc.creatorGreen, Ralph
dc.creatorFedosov, Sergey N.
dc.creatorShahab Ferdows, Setareh
dc.creatorSánchez Reyes, Hugo
dc.creatorAlbala Brevis, Cecilia
dc.creatorCastillo Carrasco, José
dc.creatorMatamala, José Manuel
dc.creatorUauy Dagach-Imbarack, Ricardo
dc.creatorAllen, Lindsay H.
dc.date.accessioned2016-05-25T15:38:07Z
dc.date.available2016-05-25T15:38:07Z
dc.date.created2016-05-25T15:38:07Z
dc.date.issued2016
dc.identifierAmerican Journal of Clinical Nutrition Volumen: 103 Número: 1 Páginas: 250-257 (2016)
dc.identifierDOI: 10.3945/ajcn.115.116509
dc.identifierhttp://repositorio.uchile.cl/handle/2250/138486
dc.description.abstractBackground: It is uncertain whether vitamin B-12 supplementation can improve neurophysiologic function in asymptomatic elderly with low vitamin B-12 status or whether folate status affects responses to vitamin B-12 supplementation. Objective: We assessed the effects of a single intramuscular injection of 10 mg vitamin B-12 (which also contained 100 mg vitamin B-6 and 100 mg vitamin B-1) on vitamin B-12 status and neurophysiologic function in elderly community-dwelling Chileans with low serum vitamin B-12 concentrations who were consuming bread fortified with folic acid. Design: A pretreatment and posttreatment study was conducted in 51 participants (median +/- SD age: 73 +/- 3 y; women: 47%) with serum vitamin B-12 concentrations <120 pmol/L at screening. Vitamin B-12 status was defined by combining vitamin B-12, plasma total homocysteine (tHcy), methylmalonic acid (MMA), and holtranscobalmin into one variable [combined indicator of vitamin B-12 status (cB-12)]. The response to treatment was assessed by measuring cB-12 and neurophysiologic variables at baseline and 4 mo after treatment. Results: Treatment increased serum vitamin B-12, holotranscobalamin, and cB-12 (P < 0.001) and reduced plasma tHcy and serum MMA (P < 0.001). Treatment produced consistent improvements in conduction in myelinated peripheral nerves; the sensory latency of both the left and right sural nerves improved on the basis of faster median conduction times of 3.1 and 3.0 ms and 3.3 and 3.4 ms, respectively (P < 0.0001). A total of 10 sensory potentials were newly observed in sural nerves after treatment. Participants with high serum folate at baseline (above the median, >= 33.9 nmol/L) had less improvement in cB-12 (P < 0.001) than did individuals whose serum folate was less than the median concentration (i.e., with a concentration <33.9 nmol/L). Conclusion: Asymptomatic Chilean elderly with poor vitamin B-12 status displayed improved conductivity in myelinated peripheral nerves after vitamin B-12 treatment and an interaction with folate status, which was detected only with the use of cB-12.
dc.languageen
dc.publisherAmerican Soc. Nutrition-ASN
dc.subjectFolate
dc.subjectVitamin B-12
dc.subjectHolotranscobalamin
dc.subjectMethylmalonic acid
dc.subjectTotal homocysteine
dc.subjectFolic acid fortification
dc.subjectNerve conductivity
dc.subjectElderly
dc.subjectChile
dc.titleVitamin B-12 treatment of asymptomatic, deficient, elderly Chileans improves conductivity in myelinated peripheral nerves, but high serum folate impairs vitamin B-12 status response assessed by the combined indicator of vitamin B-12 status
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución